Aspen Neuroscience: two ARCH funds open $38M stakes — score 73/100
Two ARCH Venture entities reporting as 10% owners bought a combined 2,533,333 shares of Aspen Neuroscience at $15.00 on 2026-11-02. Both filings report brand-new positions.
Aspen NeuroscienceConviction 73/100
In this brief: 3 sections 2 min read
• ARCH Venture Fund X, L.P. (10% owner) — 1,333,333 shares @ $15, $19,999,995, new position
• ARCH Venture Partners XIV, L.P. (10% owner) — 1,200,000 shares @ $15, $18,000,000, new position
Size carried this cluster: $37,999,995 maxed the dollar-size component at 35. Conviction also scored its full 20, because both filers report brand-new positions rather than additions. Seniority is what held the score down — at 3, reflecting that both buyers report as 10% owners rather than as officers or directors. No penalties: no same-day selling and no excluded rows.
• 2026-11-02 is the date these Form 4s were filed. The trades across today's edition were executed between 2026-10-29 and 2026-11-02; this cluster's trades are dated 2026-11-02.
• No rows were excluded from this cluster and no co-filed duplicates were collapsed.
• This is a record of what insiders reported and how the score was computed. It is not investment advice.